Abstract Five known fungal metabolites, aurasperone A, aurasperone D, averufanin, flavasperone and sterigmatocystin, were isolated from the culture broths of Aspergillus species as inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT) in the cell-based assay using ACAT1-and ACAT2-expressing CHO cells. These compounds share a similar polycyclic skeleton. Among them, flavasperone and sterigmatocystin, having an angular skeleton, showed selective inhibition toward ACAT2 isozyme, while the others having a linear one had no selectivity in inhibition.
Introduction
Acyl-CoA:cholesterol acyltransferase (ACAT), an ER membrane protein, is responsible for many functions in the body. ACAT has been recognized as a target for inhibition by a new type of antiatherosclerotic agents [1] . Many pharmaceutical laboratories have developed synthetic ACAT inhibitors. However, almost none of them could be successfully developed because of either side effects or low in vivo efficacy [2] . Recent molecular biological studies revealed the existence in mammals of two different ACAT isozymes, ACAT1 and ACAT2 [3ϳ6] . ACAT1 is ubiquitously expressed in tissues and cells, while ACAT2 is expressed predominantly in the liver (hepatocytes) and intestine [7] . ACAT1-deficient (ACAT1 Ϫ/Ϫ ) mice are viable and have a near-total depletion of cholesterol esters in their adrenal glands and peritoneal macrophages [8] . However, in addition to having dry eye syndrome, the ACAT1 Ϫ/Ϫ mice with lacking apolipoprotein E or the low-density lipoprotein receptor, as hyperlipidemic models are susceptible to atherosclerosis, had extensive cutaneous xanthomatosis with loss of hair. Free cholesterol content was significantly increased in their skin [9] . While ACAT2-deficient (ACAT2 Ϫ/Ϫ ) mice lack cholesteryl ester synthesis in the intestine and liver, ACAT2
Ϫ/Ϫ mice showed complete resistance to diet-induced hypercholesterolemia and cholesterol gallstone formation [10] . Therefore, it is important to determine the selectivity of inhibitors toward the two ACAT isozymes for their development as new antiatherosclerotic agents [11] . However, only a few studies have been reported so far [12ϳ14]. Our group has focused on the discovery of ACAT (including ACAT1 and ACAT2) inhibitors of natural origin and has improved the assay systems [15] . Recently, we utilized two cell lines, Chinese hamster ovary (CHO) cells expressing African green monkey ACAT1 (ACAT1-CHO) and ACAT2 (ACAT2-CHO) [12] . During our course of screening for ACAT inhibitors in this cell-based assay, three known compounds, aurasperone A [16, 17] , aurasperone D [18] and flavasperone [19, 20] (Fig. 1) , were isolated from the culture broths of Aspergillus sp. FKI-3451, and two known compounds, averufanin [21] and sterigmatocystin [22, 23] (Fig. 1) , were isolated from the culture broths of Aspergillus sp. FKI-3797. All these compounds share a similar polycyclic skeleton in their structures. In this study, selectivity of these compounds inhibiting toward ACAT1 and ACAT2 isozymes is described. [1- 14 C]Oleic acid was purchased from PerkinElmer Life and Analytical Sciences (USA). Fetal bovine serum (FBS) was from HyClone (USA). HAM's F12 was obtained from Sigma-Aldrich (USA). Geneticin (G-418 sulfate) was from Merck (USA). MEM vitamin solution and penicillin (10,000 units/ml)/streptomycin (10,000 m g/ml) solution were from Invitrogen (USA). Plastic microplates (48-well) were purchased from Corning (USA).
Materials and Methods

Materials
Fungal Strains
Two strains isolated from soil Aspergillus spp. FKI-3451 and FKI-3797 were used for production of aurasperones A and D, averufanin, flavasperone and sterigmatocystin. aqueous fraction was extracted EtOAc, and the organic layer was concentrated in vacuo to yield brown oil (542.2 mg). The oily material was subjected to silica gel column chromatography (10 : 0, 9 : 1, 8 : 2, 7 : 3 and 6 : 4, Hexane -EtOAc). The 8 : 2 fraction was concentrated, and the resulting materials (22.5 mg) were finally purified by HPLC (column, PEGASIL ODS (20 i.d.ϫ200 mm); mobile phase, 80% aq MeCN; flow rate, 8 ml/minute; detection, UV at 210 nm), to give averufanin (3.3 mg) and sterigmatocystin (4.7 mg) as yellow powders. 
General for Structural Determination
Structure Identification
Culture of ACAT1-and ACAT2-CHO Cells
ACAT1-and ACAT2-CHO cells were cultured by the method described previously [12] . Briefly, both cell lines were maintained at 37°C in 5.0% CO 2 in Ham's F-12 medium supplemented with MEM vitamin solution, geneticin solution, penicillin/streptomycin solution and 10% heat inactivated FBS.
Cell-based Assay for ACAT1 and ACAT2 Isozymes
Activity of ACAT1 and ACAT2 isozymes was measured using ACAT1-and ACAT2-CHO as described previously [14] . Briefly, ACAT1-or ACAT2-CHO cells (1.25ϫ10 5 cells in 250 m l of medium) were cultured in a 48-well plastic microplate in the culture medium described above and allowed to recover overnight at 37°C in 5.0% CO 2 . The assays were done with cells that were at least 80% confluent. Following the overnight recovery, 2.5 m l of a sample (added as a MeOH solution to make a final concentration of 0ϳ100 mg/ml) and 5.0 ml of [1- 14 C]oleic acid (1.0 nmol, 1.85 KBq, 10% EtOH/PBS solution) were added to each culture. After a 6-hour incubation at 37°C in 5.0% CO 2 , the medium was removed, and the cells in each well were washed twice with PBS. The cells were lysed by adding 0.25 ml of 10 mM Tris-HCl (pH 7.5) containing 0.1% (w/v) sodium dodecyl sulfate, and [
14 C]cholesteryl ester (CE) was analyzed with a BAS2000 analyzer (Fuji Film). In this cell-based assay, [ 14 C]CE was produced by the reaction of ACAT1 or ACAT2. ACAT inhibitory activity (%) is defined as (1Ϫ[
14 C]CE-drug/[ 14 C]CEcontrol)ϫ100. The IC 50 value is defined as the drug concentration causing 50% inhibition of a biological activity.
Results and Discussion
Five structurally related compounds, aurasperone A, aurasperone D, averufanin, flavasperone, and sterigmatocystin, were evaluated in the cell-based assay using ACAT1-and ACAT2-CHO cells to assess the selectivity toward ACAT1 and ACAT2 isozymes. All the compounds showed no cytotoxic effects up to 60 m M on both ACAT1-and ACAT2-CHO cells in the assay period (6 hours). The IC 50 values toward ACAT1 and ACAT2 isozymes are summarized in Table 1 . Aurasperones and averufanin inhibited both ACAT1 and ACAT2 and aurasperones A and D (selectivity index (SI): 4.0 and 4.7, respectively) are slightly more selective than averufanin (SI: 2.3). On the other hand, flavasperone and sterigmatocystin showed rather selective inhibition toward ACAT2 with SI of Ͼ10. These compounds (Fig. 1) share a similar polycyclic skeleton such as naphtho-g -pyrone or anthraquinone. In general, the words, "linear" and "angular", are used for compounds with a polycyclic skeleton, such as naphtho-g -pyrone (aurasperone or flavasperon), anthraquinone (averufanin) or xanthone (sterigmatocytin) in many papers [24ϳ26] . Among them, flavasperone and sterigmatocystin have an angular type of the polycyclic skeleton, while the others have a linear type. Fungal pyripyropene A, well known as a highly selective ACAT2 inhibitor [12, 14] , also has an angular backbone (Fig. 1) . Very recently, it was demonstrated that pyripyropene A is non-covalently bound to the specific site (492Q, 493V and 494S) of ACAT2 isozyme [27] . Therefore, it might be that compounds having an angular type of polycyclic skeleton are accessible to the site of ACAT2 to exhibit selective inhibition.
Some of these compounds were previously reported to show different biological activities. Aurasperone A inhibits xanthine oxidase [28] , aurasperone D shows depressant activity of central nerve system [18] . As described in this study, the angular compounds, flavasperone and sterigmatocystin, were found to inhibit ACAT2 isozymes selectively. The data are expressed at the mean (Nϭ3).
